Correlation Between Viking Therapeutics and Nanologix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Nanologix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Nanologix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Nanologix, you can compare the effects of market volatilities on Viking Therapeutics and Nanologix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Nanologix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Nanologix.

Diversification Opportunities for Viking Therapeutics and Nanologix

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Viking and Nanologix is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Nanologix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nanologix and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Nanologix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nanologix has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Nanologix go up and down completely randomly.

Pair Corralation between Viking Therapeutics and Nanologix

Given the investment horizon of 90 days Viking Therapeutics is expected to under-perform the Nanologix. But the stock apears to be less risky and, when comparing its historical volatility, Viking Therapeutics is 35.54 times less risky than Nanologix. The stock trades about -0.19 of its potential returns per unit of risk. The Nanologix is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  0.00  in Nanologix on October 26, 2024 and sell it today you would earn a total of  0.01  from holding Nanologix or generate 9.223372036854776E16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Viking Therapeutics  vs.  Nanologix

 Performance 
       Timeline  
Viking Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viking Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Nanologix 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Nanologix are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting essential indicators, Nanologix showed solid returns over the last few months and may actually be approaching a breakup point.

Viking Therapeutics and Nanologix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viking Therapeutics and Nanologix

The main advantage of trading using opposite Viking Therapeutics and Nanologix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Nanologix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanologix will offset losses from the drop in Nanologix's long position.
The idea behind Viking Therapeutics and Nanologix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets